Erkrankte mit ärztlich diagnostizierter Myalgischer Enzephalomyelitis/chronischem Fatigue-Syndrom (ME/CFS-) im Vergleich zu Erkrankten, die vermuten an ME/CFS zu leiden
Prävention und Gesundheitsförderung,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 5, 2025
Health-related quality of life in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post COVID-19 Condition: a systematic review
Journal of Translational Medicine,
Год журнала:
2025,
Номер
23(1)
Опубликована: Март 13, 2025
Abstract
Purpose
Myalgic
Encephalomyelitis/Chronic
Fatigue
Syndrome
(ME/CFS)
and
Post
COVID-19
Condition
(PCC)
are
debilitating,
chronic
multi-systemic
illnesses
that
require
multidisciplinary
care.
However,
people
with
ME/CFS
(pwME/CFS)
PCC
(pwPCC)
often
precluded
from
accessing
necessary
disability
social
support
services.
These
unmet
care
needs
exacerbate
the
existing
illness
burdens
experienced
by
pwME/CFS
pwPCC.
To
deliver
appropriate
optimise
health
outcomes
for
pwPCC,
development
of
evidence-based
healthcare
policies
recognise
disabling
impacts
these
must
be
prioritised.
This
systematic
review
summarises
health-related
quality
life
(HRQoL)
pwPCC
when
compared
healthy
controls
(HCs)
to
elucidate
guide
policy
reform.
Methods
CINAHL,
Embase,
MEDLINE,
PubMed,
PsycINFO
Web
Science
Core
Collection
were
systematically
searched
1st
January
2003
23rd
July
2024.
Eligible
publications
included
observational
studies
capturing
quantitative
HRQoL
data
among
or
HCs.
The
use
validated
patient-reported
outcome
measures
(PROMs)
was
mandatory.
also
required
employ
most
stringent
diagnostic
criteria
currently
available,
including
Canadian
Consensus
Criteria
International
World
Health
Organization
case
definition
(PROSPERO
ID:
CRD42024501309).
Results
captured
16
studies,
eight
pwME/CFS,
seven
one
study
both
cohorts.
Most
participants
female
middle-aged.
All
had
prolonged
symptoms
at
least
three
months.
When
HCs,
all
domains
significantly
impaired
Both
a
salient
impact
on
physical
health,
pain
ability
perform
daily
work
activities.
While
direct
comparisons
between
limited
inconsistencies
in
PROMs
employed,
comparable
trends
across
domain
scores
observed.
Conclusion
have
similar,
profound
warrant
access
Future
research
harmonise
collection
prioritise
longitudinal
investigations
characterise
subgroups
(including
those
fulfilling
criteria)
predictors
prognosis.
Язык: Английский
Variant connective tissue as a risk factor for Long COVID: a case-control study
Research Square (Research Square),
Год журнала:
2025,
Номер
unknown
Опубликована: Март 20, 2025
Abstract
Long
COVID
(LC)
is
a
major
medical
challenge,
with
approximately
20
million
sufferers
in
the
US
and
UK
alone.
Determining
risk
factors
for
LC
of
utmost
importance
to
aid
effective
preventative
treatment.
We
assessed
whether
variant
connective
tissue,
known
factor
several
illnesses,
predictive
risk.
administered
survey
1,816
respondents
recruited
from
representative
online
panels
assessing
joint
hypermobility
status.
In
separate
well-controlled
binomial
logistic
regressions,
both
generalized
(OR
1.29,
95%
CI
1.00
1.65)
extreme
2.12,
1.43
3.16)
were
LC.
Our
findings
suggest
that
influences
odds
developing
by
increasing
likelihood
severe
initial
symptoms
COVID-19
individuals
no
or
moderate
experience
Язык: Английский
Long COVID in 2025: a clinical viewpoint
Life Sciences,
Год журнала:
2025,
Номер
unknown, С. 123633 - 123633
Опубликована: Апрель 1, 2025
Язык: Английский
A pilot cross-sectional investigation of symptom clusters and associations with patient-reported outcomes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post COVID-19 Condition
Quality of Life Research,
Год журнала:
2024,
Номер
33(12), С. 3229 - 3243
Опубликована: Окт. 3, 2024
Abstract
Background
Myalgic
Encephalomyelitis/Chronic
Fatigue
Syndrome
(ME/CFS)
is
associated
with
long-term
disability
and
poor
quality
of
life
(QoL).
Cardinal
ME/CFS
symptoms
(including
post-exertional
malaise,
cognitive
dysfunction
sleep
disturbances)
have
been
observed
in
Post
COVID-19
Condition
(PCC).
To
gain
further
insight
into
the
potential
role
as
a
post-COVID-19
sequela,
this
study
investigates
associations
between
patient-reported
outcomes,
well
symptom
clusters.
Methods
Participants
included
Australian
residents
aged
18
65
years
formally
diagnosed
fulfilling
Canadian
or
International
Consensus
Criteria
PCC
meeting
World
Health
Organization
case
definition.
Validated,
self-administered
questionnaires
collected
participants’
sociodemographic
illness
characteristics,
symptoms,
QoL
functional
capacity.
Associations
outcomes
were
investigated
multivariate
linear
regression
models.
Hierarchical
cluster
analysis
was
performed
to
identify
Results
Most
people
(pwME/CFS)
(pwPCC)
female
(
n
=
48/60,
80.0%
19/30,
63.3%,
respectively;
p
0.12).
PwME/CFS
significantly
younger
x̄
=41.75,
s
12.91
years)
than
pwPCC
=48.13,
=10.05
years;
=0.017).
Autonomic
(notably
dyspnoea)
poorer
scores
most
outcome
domains
for
both
cohorts.
None
four
clusters
identified
unique
PCC.
Clusters
largely
delineated
by
presence
gastrointestinal
neurosensory
duration,
criteria
met
total
symptoms.
Conclusions
Illness
duration
may
explain
differences
burden
pwME/CFS
pwPCC.
diagnostic
must
be
refined
distinguish
at
risk
ME/CFS-like
subsequently
deliver
necessary
care
support.
Язык: Английский
Effects of a symptom-titrated exercise program on fatigue and quality of life in people with post-COVID condition – a randomized controlled trial
Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Дек. 16, 2024
Язык: Английский
A Personalised Pacing and Active Rest Rehabilitation Programme for Post-Exertional Symptom Exacerbation and Health Status in Long COVID (PACELOC): A Prospective Cohort Study
Belinda Godfrey,
Jenna Shardha,
Sharon Witton
и другие.
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
14(1), С. 97 - 97
Опубликована: Дек. 27, 2024
Background:
Post-COVID-19
Syndrome
or
long
COVID
(LC)
is
a
novel
public
health
crisis
and,
when
persistent
(>2
years),
long-term
condition.
Post-exertional
symptom
exacerbation
(PESE)
characteristic
of
LC
and
can
be
improved
in
structured
pacing
rehabilitation
programme.
Aims:
To
evaluate
the
effect
an
8-week
World
Health
Organisation
(WHO)
Borg
CR-10
protocol
on
PESE
episodes,
symptoms,
quality
life
cohort
individuals
with
LC.
Methods:
Participants
received
weekly
telephone
calls
clinician
to
discuss
their
activity
phase,
considering
symptoms
that
week.
They
completed
Leeds
questionnaire
(LPQ),
C19-YRS
(Yorkshire
Rehabilitation
Scale),
EQ-5D-5L
at
beginning
programme
(0
weeks),
end
(8
final
follow-up
(12
weeks).
Results:
Thirty-one
participants
(duration
symptoms:
29
months)
The
episodes
decreased
number
each
week
(15%
fewer
week,
95%
CI:
11%
20%,
p
<
0.001)
were
shorter
duration
milder
severity
changes
C19YRS
functional
disability
(0–12
weeks)
statistically
significant
but
not
clinically
significant.
EQ5D-5L
index
score
change
was
Conclusions:
A
effectively
reduced
episode
frequency,
duration,
did
produce
reflecting
nature
condition
this
cohort.
Язык: Английский